India is the ‘diabetes capital of the world’. A recent report published in The Lancet confirmed this, saying the South Asian ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and ...

More than 800 million adults have diabetes worldwide – almost twice as many as previous estimates have suggested.

Discover the history of insulin, from its discovery to modern production methods, and the ongoing quest for a cure.